Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway
Gu, C., Liu, Y., Yin, Z. Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway. Mol Ther Nucleic Acids. (2019). https://doi.org/10.1016/j.omtn.2019.01.015
Read more
Sumoylation of RORγt regulates TH17 differentiation and thymocyte development
Nature Communications 9, 4870 (2018).
Read more